Chargement en cours...

Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells

Breast cancer is a common malignancy among women. The innate and adaptive immune responses failed to be activated owing to immune modulation in the tumour microenvironment. Decades of scientific study links the overexpression of human epidermal growth factor receptor 2 (ERBB2) antigen with aggressiv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Munisvaradass, Rusheni, Kumar, Suresh, Govindasamy, Chandramohan, Alnumair, Khalid S., Mok, Pooi Ling
Format: Artigo
Langue:Inglês
Publié: MDPI 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5618474/
https://ncbi.nlm.nih.gov/pubmed/28885562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18091797
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!